What does Atreca, Inc. do?

Jun 22 2025 06:19 PM IST
share
Share Via
Atreca, Inc. is a biotechnology company focused on developing cancer therapeutics based on human immune responses, currently operating at a market cap of $3.57 million with no net sales and a quarterly net loss of $36 million as of September 2023.
Overview:
Atreca, Inc. is a biotechnology company engaged in developing therapeutics derived from human immune responses, particularly in cancer treatment, and operates within the micro-cap market.

Financial Snapshot:
Most recent Net Sales: 0 Million (Quarterly Results - Sep 2023)
Most recent Net Profit: -36 Million (Quarterly Results - Sep 2023)
Market-cap: USD 3.57 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.97
Return on Equity: -710.58%
Price to Book: 0.33

Contact Details:
Address: 450 East Jamie Court, SOUTH SAN FRANCISCO CA: 94080
Tel: 1 650 5952595
Fax: 1 650 4532410
Website: http://www.atreca.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Atreca, Inc. overvalued or undervalued?
Jun 25 2025 08:34 AM IST
share
Share Via
Who are in the management team of Atreca, Inc.?
Jun 22 2025 10:16 PM IST
share
Share Via
Most Read